Matrix-designed bright near-infrared fluorophores for precision peripheral nerve imaging.

The FDA's recent approval of pafolacianine, the first molecular targeted contrast agent for fluorescence-guided surgery (FGS), signifies a remarkable milestone in precision medicine. This advance offers new hope for cancer patients by enabling guided removal of cancerous tissues, where completed surgical removal remains a consistent challenge without real-time intraoperative guidance. For optimal surgical outcomes, delicate nerve tissues must be preserved to maintain patient quality of life.

Prevalence of in unpasteurized dairy products in west of Iran.

Q fever is a zoonotic disease caused by . This study investigated the prevalence of in traditional dairy products, specifically yogurt and cheese, in Lorestan Province. A total of 100 samples of traditional yogurt and unpasteurized cheese were collected from various regions.

Retrobulbar Hematoma: Presentation, Management, and Visual Outcomes.

Retrobulbar hematoma (RH) is a diagnostic and therapeutic emergency that may cause permanent vision loss. Lateral canthotomy and cantholysis (LCC) is typically performed when IOP is elevated or vision is compromised. The authors describe the outcomes of the largest cohort of patients with RH to date.

Long-Term Effects of Fertility Treatments on Maternal Health.

Background The long-term health effects of assisted reproductive technologies, including in vitro fertilization (IVF) and hormonal therapies, remain poorly understood. This highlights the need to investigate potential chronic conditions that may arise following treatment. Objective The objective of this study was to investigate the long-term effects of fertility treatments on maternal health, with a focus on the incidence of chronic conditions and overall health outcomes in women who have undergone such treatments.

Two-color fluorescence-guided surgery for head and neck cancer resections.

Significance: Head and neck squamous cell carcinoma (HNSCC) has the sixth highest incidence worldwide, with cases annually. Surgery is the primary treatment option for HNSCC, during which surgeons balance two main goals: (1) complete cancer resection and (2) preservation of normal tissues to ensure post-surgical quality of life. Unfortunately, these goals are not synergistic, where complete cancer resection is often limited by efforts to preserve normal tissues, particularly nerves, and reduce life-altering comorbidities.